Exclusive: Cigna drops coverage of GLP-1 obesity drugs for its own employees

Health insurer Cigna will ​stop covering GLP-1 weight-loss ‌drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in ​its employee health plan ​effective July 1, according to ⁠materials viewed by Reuters on ​Tuesday.